Inicio › Cáncer metastásico › Arizona › Tucson
Ensayos clínicos de Cáncer metastásico en Tucson, AZ
14 estudios para Cáncer metastásico buscan participantes en centros de Tucson y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
ReclutandoFase 1
- University of Arizona Cancer Center, Tucson
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutandoFase 2/3
- The University of Arizona Cancer Center, Tucson
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutandoFase 2
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutandoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ReclutandoFase 3
- University of Arizona-Cancer Center, Tucson
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- University of Arizona - Cancer Center, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Arizona Cancer Center at University of Arizona, Tucson
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Tucson
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
Reclutando
- University of Arizona Cancer Center, Tucson
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
ReclutandoFase 3
- The University of Arizona Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- The University of Arizona Cancer Center, Tucson
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
ReclutandoFase 1
- University of Arizona, Tucson
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Tucson
- Cáncer de seno20 estudios
- Obesidad18 estudios
- Cáncer de pulmón de células no pequeñas17 estudios
- Sobrepeso15 estudios
- Cáncer (todos los tipos)12 estudios
- Enfermedad cardiovascular12 estudios
- Cáncer del colon y del recto11 estudios
- Cáncer de próstata11 estudios
- Diabetes tipo 211 estudios
- Esteatosis hepática10 estudios
- Fallo cardíaco10 estudios
- Presión arterial alta10 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.